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The goal of my research is the progress toward an efficient synthesis of a phenyl omuralide analog (Figure 7). This compound has been synthesized previously 
and shown to not inhibit the cellular proteasome, but it is not known whether it inhibits 
CPAF.15,16,17,18 This compound is not available from the original source for testing 
against CPAF. Synthesis of this compound needs careful stereochemical control due to 
the four chiral centers. The phenyl group must be added as late as possible in the 
synthesis for the efficient synthesis of other analogs and the β-lactone ring must be closed 
late. The synthesis being attempted is shorter than the synthesis of the compound done by 
Corey15,18 and is based on the synthesis done by Soucy of a potent analogue of clasto-
lactacystin β-lactone, for the treatment of ischemia-reperfusion injury.19  The analog 
synthesized by Soucy has the isopropyl, like omuralide, instead of the phenyl but instead 
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